Gregory Lyford, MD
NPI 1215975339 · Gastroenterology Physician · Nixa, MO
Provider details
- NPI number
- 1215975339
- Entity type
- Individual
- Primary specialty
- Gastroenterology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- 2004007608 (MO)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
705 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Moderate Sedation Services Provided By the Same Physician Or Other Qualified Health Care Professional Performing a Gastrointestinal Endoscopic Service That Sedation Supports, Requiring the Presence of an Independent Trained Observer to Assist in the MonitoG0500 | 209 | $5 |
| Removal of Polyps Or Growths of Large Bowel Using an Endoscope With Mechanical Snare45385 | 84 | $232 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 52 | $62 |
| Established Patient Office Or Other Outpatient Visit With Straightforward Medical Decision Making, If Using Time, 10 Minutes Or More99212 | 50 | $33 |
| Colorectal Cancer Screening; Colonoscopy on Individual at High RiskG0105 | 49 | $169 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 27 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Metoclopramide Hcl | 365 | 348 |
| Sodium Chloride/Nahco3/Kcl/Pegbrand: Peg 3350-Electrolyte | 302 | 295 |
| Omeprazole | 103 | 33 |
| Colestipol Hcl | 75 | 17 |
| Mesalamine | 46 | 15 |
| Azathioprine | 41 | 13 |
| Ursodiol | 40 | — |
| Sucralfate | 38 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$94 across 5 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-06-02
- Last updated
- 2024-12-02
- Certified
- 2024-12-02
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.